Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Report 2016

Publisher Name :
Date: 09-Oct-2016
No. of pages: 126
Inquire Before Buying

Notes:

Sales, means the sales volume of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Revenue, means the sales value of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

This report studies sales (consumption) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Conatus Pharmaceuticals

- Daewoong Pharmaceutical

- Galmed International

- Kyorin Pharmaceutical

- Metabolic Solutions Development

- Novartis AG

- Phenex Pharmaceuticals

- Raptor Pharmaceuticals

- TCM Biotech International

- Tobira Therapeutics

- Verva Pharmaceuticals

- Zafgen

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on sales, market share and growth rate of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in each application, can be divided into

- Application 1

- Application 2

- Application 3

Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Report 2016

Table of Contents
Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Report 2016
1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
1.1 Product Overview and Scope of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug (2011-2021)
1.5.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2021)
1.5.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Manufacturers, Type and Application
2.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competition by Manufacturers
2.1.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Type
2.2.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2011-2016)
2.2.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2011-2016)
2.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Countries
2.3.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Countries (2011-2016)
2.4 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume) by Application
3 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
3.1 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2011-2016)
3.1.1 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
3.1.2 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
3.1.3 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
3.2 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
3.3 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
3.4 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
4 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
4.1 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2011-2016)
4.1.1 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
4.1.2 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
4.1.4 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
4.2 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
4.3 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
4.4 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
5 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
5.1 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2011-2016)
5.1.1 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
5.1.2 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
5.1.5 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
5.2 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
5.3 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
5.4 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
6 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
6.1 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2011-2016)
6.1.1 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
6.1.2 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
6.1.6 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
6.2 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
6.3 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
6.4 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
7 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
7.1 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2011-2016)
7.1.1 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
7.1.2 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
7.1.7 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
7.2 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
7.3 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
7.4 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
8 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
8.1 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2011-2016)
8.1.1 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
8.1.2 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
8.1.8 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
8.2 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
8.3 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
8.4 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
9 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
9.1 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2011-2016)
9.1.1 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
9.1.2 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
9.2 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
9.3 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
9.4 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
10 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturers Analysis
10.1 Conatus Pharmaceuticals
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Daewoong Pharmaceutical
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Galmed International
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Kyorin Pharmaceutical
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Metabolic Solutions Development
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Novartis AG
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Phenex Pharmaceuticals
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Raptor Pharmaceuticals
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 TCM Biotech International
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Tobira Therapeutics
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 Verva Pharmaceuticals
10.12 Zafgen
11 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Cost Analysis
11.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast (2016-2021)
14.1 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast (2016-2021)
14.2 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast (2016-2021)
14.3 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast (2016-2021)
14.4 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast (2016-2021)
14.5 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast (2016-2021)
14.6 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast (2016-2021)
14.7 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast (2016-2021)
14.8 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Type (2016-2021)
14.9 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Europe Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Europe Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2021)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2021)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers
Figure 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table 2016 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2011-2016)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Type (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2011-2016)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Growth Rate by Type (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Countries (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Countries (2011-2016)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Countries (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Countries (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Countries (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application (2011-2016)
Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)
Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)
Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)
Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)
Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)
Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)
Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)
Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)
Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)
Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)
Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)
Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)
Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)
Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)
Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)
Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)
Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)
Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)
Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)
Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)
Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)
Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)
Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)
Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)
Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)
Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)
Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)
Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)
Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)
Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)
Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)
Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)
Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2011-2016)
Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2011-2016)
Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2011-2016)
Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)
Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)
Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)
Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)
Table Non-alcoholic Fatty Liver Disease (NAFLD) Drug Basic Information List
Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2011-2016)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2011-2016)
Table Galmed International Basic Information List
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2011-2016)
Table Kyorin Pharmaceutical Basic Information List
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2011-2016)
Table Metabolic Solutions Development Basic Information List
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2011-2016)
Table Novartis AG Basic Information List
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2011-2016)
Table Phenex Pharmaceuticals Basic Information List
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2011-2016)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2011-2016)
Table TCM Biotech International Basic Information List
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2011-2016)
Table Tobira Therapeutics Basic Information List
Table Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2011-2016)
Table Verva Pharmaceuticals Basic Information List
Table Verva Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Verva Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2011-2016)
Table Zafgen Basic Information List
Table Zafgen Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zafgen Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
Table Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
Table Major Buyers of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Distributors/Traders List
Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2016-2021)
Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2016-2021)
Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2016-2021)
Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2016-2021)
Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2016-2021)
Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2016-2021)
Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2016-2021)
Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2016-2021)
Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2016-2021)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Type (2016-2021)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2016-2021)
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • Efficacy of Stand-alone Power Sources Drive The Global Distributed Energy Generation Market
    The global market for distributed energy generation is expected to magnify at a momentous CAGR of 11.4% between 2016 and 2020. The small-scale generation of electricity, oscillating from a few kilowatts to multitudes of megawatts, is denoted as distributed energy generation. In this process, power is usually produced using renewable resources or by generators during consumption. [...]
  • Global Organic Food Market Makes A Mark in Developed Economies
    Buyers throughout the world are becoming more and more health cognizant, which has occasioned in an alteration in their palates and inclinations. The global organic food market was worth US$88.1 billion in 2015 is anticipated to record a CAGR of over 16% between 2015 and 2020. Amongst the various different food products available, the fruits [...]
  • Global Soft Gelatin Capsules Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 20-Jan-2017        Price: US 3480 Onwards        Pages: 111
    Soft Gelatin Capsules: These are also called as softgel. Soft gelatin capsules are manufactured as single piece capsule shell.Soft Gelatin Capsules are a type of capsules with a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both.Scope of the Report:This report focuses on the Soft Gelatin Capsules in Global market, especially in North America, Europe and Asia......
  • Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017
    Published: 19-Jan-2017        Price: US 2900 Onwards        Pages: 128
    Notes: Production, means the output of Viral Vectors and Plasmid DNA Manufacturing Revenue, means the sales value of Viral Vectors and Plasmid DNA Manufacturing This report studies Viral Vectors and Plasmid DNA Manufacturing in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Alde......
  • United States Wound Care Sealants Market Report 2017
    Published: 19-Jan-2017        Price: US 3800 Onwards        Pages: 95
    Notes: Sales, means the sales volume of Wound Care Sealants Revenue, means the sales value of Wound Care Sealants This report studies sales (consumption) of Wound Care Sealants in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - - Baxter - - Cryolife - - Medtronic - - CSL Behring - - Davol - - Genzyme - - Ethicon - - Takeda - - Pfize......
  • Global Biochemical Reagent Market Research Report 2017
    Published: 19-Jan-2017        Price: US 2900 Onwards        Pages: 126
    Notes: Production, means the output of Biochemical Reagent Revenue, means the sales value of Biochemical Reagent This report studies Biochemical Reagent in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Thermo Fisher Scientific - Merck Millipore - Sigma-Aldrich Cor......
  • Global Fibrin Glue Market Research Report 2017
    Published: 19-Jan-2017        Price: US 2900 Onwards        Pages: 126
    Notes: Production, means the output of Fibrin Glue Revenue, means the sales value of Fibrin Glue This report studies Fibrin Glue in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Baxter International - CSL Behring - Johnson&Johnson - Harvest Technologies......
  • Global Dialysis Powder Market Research Report 2017
    Published: 19-Jan-2017        Price: US 2900 Onwards        Pages: 129
    Notes: Production, means the output of Dialysis Powder Revenue, means the sales value of Dialysis Powder This report studies Dialysis Powder in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Asahi Kasei Medical - Baxter International - B. Braun Melsungen - D......
  • Global Human Factor IX Market Research Report 2017
    Published: 19-Jan-2017        Price: US 2900 Onwards        Pages: 126
    Notes: Production, means the output of Human Factor IX Revenue, means the sales value of Human Factor IX This report studies Human Factor IX in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Pfizer - Biogen - Enzo Life Sciences - Feldan - Santa Cruz B......
  • Global Quit Smoking Drug Market Research Report 2017
    Published: 19-Jan-2017        Price: US 2900 Onwards        Pages: 121
    Notes: Production, means the output of Quit Smoking Drug Revenue, means the sales value of Quit Smoking Drug This report studies Quit Smoking Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Aradigm - Roche - BGP Group - Boots - Cochrane Collabo......
  • Global Amantadine Hydrochloride Market Research Report 2017
    Published: 19-Jan-2017        Price: US 2900 Onwards        Pages: 125
    Notes: Production, means the output of Amantadine Hydrochloride Revenue, means the sales value of Amantadine Hydrochloride This report studies Amantadine Hydrochloride in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Sandoz - MIKART - Pai - WOCKHARDT ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs